therefore, to estimate the collective impact of such risk factors together, to support the identification of appropriate precautionary measures promptly.
Cesarean sections (CS) are associated with increased blood loss, and worldwide CS rates are on the rise. 12 It is therefore important that prophylactic measures aimed at reducing the risk of PPH are incorporated into standard clinical practice. Previous prediction tools have not been validated with further data analysis.
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Objective
The aim is to identify the specific combinations of risk factors that can lead to a higher blood loss during a CS, and to quantify these risks. The ability to accurately predict the risk of blood loss would enable preventative measures to be undertaken, thus reducing the frequency of PPH and the morbidity and mortality that follows. Second, the newly developed toolkit will be validated within our multiethnic population.
Study Design
This study was performed as a retrospective cohort study at a university hospital trust in the United Kingdom with a multiethnic population. Data of all CS performed at this trust between January 2003 and December 2013 were gathered from the hospital electronic database. Database searches were supplemented by case notes review. Data for all women undergoing a CS were coded to include the estimated blood loss at CS and 18 identified risk factors for PPH, shown in ►Table 1. Electronic text was searched independently for risk factors not otherwise identified.
Patients were randomly split into two groups; a training group consisting of 75% (N ¼ 18,172) of the patients, and a validation group consisting of the remaining 25% (N ¼ 6,058).
The training group was analyzed by Hothorn et al's nonparametric recursive partitioning algorithm.
14 The algorithm starts by splitting the data into two subgroups, according to the risk factor that leads to the greatest statistically significant difference in terms of blood loss. The same process is then repeated for the subgroups with respect to different risk factors, continuing recursively until a termination criterion is achieved (described below). The result is a decision tree, 15 whereby the root of the tree corresponds to a split along the lines of the most significant risk factor that spans the entire population of patients, and branches correspond to subgroups. The minimal threshold for this splitting procedure is specified as the minimal statistical significance that should be achieved by a given split (the maximum p value). We selected this parameter by the process of adaptive resampling, 16 where several p values were attempted; the final p value was chosen that produced the lowest root mean squared error computed by fivefold cross-validation. This led to the choice of a minimum threshold of 0.01. In other words, the recursive partitioning would terminate if no split could be found that produced different blood loss levels where p < 0.01. For each branch in the decision tree (i.e., every distinct group and subgroup of patients contained in the tree), the blood loss data for that specific group of patients were analyzed, and the probabilities of producing a blood loss 1,000 and 2,000 mL were calculated. The remaining 25% unseen data were used to validate the accuracy of the probabilities computed for the various combinations of risk factors. For each of the identified combinations of risk factors, the probabilities of the likelihoods of 1,000 and 2,000 mL blood loss were calculated, and were compared with the corresponding probabilities for the training data. This comparison was quantified in terms of how correlated the two sets of probabilities are, and also in terms of the mean absolute error, which was computed as:
, where p i denotes the predicted value for patient i, and a i represents the actual value for patient i.
Results
A total number of 24,230 CS were included in this study. Of which, 8,736 (36.1%) were elective and 15,494 (63.9%) were emergency procedures. Out of 24,230, a total of 2,997 (12.4%) women had a blood loss of more than 1,000 mL.
From the 18 risk factors in the data, the recursive partitioning algorithm highlighted 9 as contributing, either individually or in combination with each other, to blood loss levels (►Table 2). The resulting decision tree model is shown in ►Fig. 1. To interpret this, one starts from the top node, which starts from the most significant decision, and works down through the subsequent factors until a leaf-node is reached, where the probability of blood loss being 1,000 and 2,000 mL is given. The tree-structure imparts a hierarchy of the risk factors that are of particular concern for blood loss. Faced with a patient with a multitude of potential risk factors, the tree-structure makes it clear that the questions of placenta previa and previous CS take precedence over all others. Additionally, the question of multiple pregnancies only appears to be a significant factor for Asian patients and is overridden by the question of a large body mass index (BMI) in any case.
Placenta previa is the main risk factor, leading to a 45.5% chance of 1,000 mL and a 17.5% chance of 2,000 mL estimated blood loss (EBL), respectively. However, this is hugely exacerbated when combined with a previous CS, where the probabilities rise to 58.3 and 31.2%, respectively. Independently, antepartum hemorrhage (APH) is associated with a 41.9 and 12.4% chance of an EBL 1,000 and 2,000 mL, respectively.
There are many different paths through the decision tree; the following are a few examples. Let us consider a patient with no placenta previa or APH, but there has been a previous CS if the subsequent CS is an emergency the patient has a 1 in 10 chance of PPH 1,000 mL. If it is not an emergency, but their BMI is greater than 35 the patient again has a PPH risk of 10.3%. Then, if you do not have a raised BMI, whether you are a grand multipara becomes important, and you have a risk of 13.8% of EBL 1,000 mL.
If no history of previa, APH or previous CS, BMI is again an important risk factor and the risk of 1,000 mL is 18.5%. If BMI was less than 35, the patient was of Asian ethnicity, and it was a multiple pregnancy, the associated EBL would be 1,000 mL in 22.8%. Preeclampsia/pregnancy-induced hypertension and being of Asian origin was associated with low EBL of 1.1% of blood loss 1,000 mL.
Validation of the predictions for blood loss of 1,000 and 2,000 mL against the cohort of patients who were not used for model inference indicates that the predictions are accurate. A comparison of the probabilities predicted from the training data, and the corresponding probabilities within the validation data are shown in ►Fig. 2. The mean absolute error is 239.8 mL, which is reasonably accurate, and the interclass correlation between the predicted mean EBL and actual mean EBL is 0.98. The correlation between predicted percentage 1,000 mL and actual blood loss 1,000 mL is 0.97, shown in ►Fig. 2. For 2,000 mL the correlation is 0.96, shown in ►Fig. 3.
It is noteworthy that, contrary to previous results, 11 the inferred model does not highlight fibroids as influencing blood loss. This should not be interpreted as meaning that fibroids are not a factor. However, our dataset only contained 37 patients with fibroids (and the 75% sample used for training the model contained only 28). Furthermore, many of these patients also exhibited other factors that did feature in the model (only nine patients with fibroids did not have other characteristics that also feature in the model). Nevertheless, looking at the statistics for those patients with fibroids, the mean blood loss is 809.459 mL, the probabilities of 1,000 and 2,000 mL are 32.4 and 5.4%, respectively, so Predicting PPH during Cesarean Delivery Dunkerton et al. 165
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the data (albeit with few data points) still corroborates that the presence fibroids is a potentially significant factor.
Discussion
Risk models have been successfully used in medicine and surgery to prepare clinicians with safety tools. These models help patients to understand their individualized risk, which is much closer to reality than the background population risk. Such risk prediction helps patients to make an informed decision and consider alternatives to proposed treatment. In surgery, Parsonnet et al created an additive model to predict the chance of mortality within 30 days after cardiac surgery for adult acquired heart disease. 17 It was then tested prospectively and shown to have an excellent correlation between expected and observed mortality. Like our current model, Parsonnet's model was based on the data from one unit. When applied to other units there was a slight variance in predicted mortality, but it inspired Nashef et al to create the EuroScore using multicenter data which is now a highly regarded and well-used risk model. 18 The current model to predict PPH could similarly form the foundation for a multicenter study.
Risk factors for PPH have been described in other studies. Multiple pregnancies 2 causes extrauterine distension compared with a singleton, making it less efficient at returning to its contracted state and susceptible to bleeding. Previa is associated with a high incidence of PPH in some studies, which would be in agreement with our results. 2,19 APH 19 and raised BMI 5 have been previously associated with complications including PPH. The novel result of this study was the ability to quantify and individualize the risk for women undergoing CS. The proposed tool has many advantages over the traditionally used qualitative risk assessment approach. In addition to improving patient safety and care, these models provide a basis for standardized comparison of the incidence of this complication across different units. Comparison of PPH rates alone without accounting for the complexity of patient risk factors and demographics could be biased.
A paper risk assessment tool has been used to help prevent obstetric venous thromboembolism (VTE) which is widely used and forms part of the RCOG green top for prevention of VTE. 20 The Leicester PPH predict tool could form a part of the pretheater checklist and these tools are increasingly being implemented as mobile applications in other specialties. Nogueira et al have created an application to use prehospital to triage patients using simple yes/no answers to help direct them to the appropriate hospital for their care. 21 Our tool has been developed into a free online Web site. 22 This allows the user to click yes or no to each patient characteristic question, producing as output a probability of blood loss 1,000 and 2,000 mL. This online tool is available to be used by other units globally for clinical and research purposes; please note information inputted will be stored anonymously on the Web site but not utilized for any purpose. This could also provide an opportunity for the external validity of this tool. Medical data has increased in quantity over the last few decades and machine learning techniques, such as we have used in our statistical analysis, allow far more complex relationships to be revealed compared with standard methods of data processing. The decision tree is especially useful because it is sensitive to the more subtle interrelationships between factors. So, for example in our model, the question of whether you have had a previous CS is particularly important if you also had a placenta previa. Scheer et al created a computer based preoperative predictive model for an orthopedic complication using a similar split of trained and untrained data. It was shown to have 86% accuracy at predicting the complication. 23 Suta et al developed a simple score system using traditional multivariate analysis for predicting PPH in Thailand at CS using retrospective data on 2,405 patients with an overall prevalence of PPH of 10.1%.
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Similarly, they found previa, emergency CS, multiparity to increase the risk of PPH. Having a risk assessment tool allows consideration of what might be required to prevent or deal with the PPH. Those at lower risk would have the routine five unit intravenous syntocinon. If stratified as a medium risk then administration of prophylactic 40 units or carbetocin and other oxytocics/ balloons could be available if required. Then those at higher risk could be delivered in a unit with access to cell salvage, gynecological theater equipment, crossed matched blood, embolization, senior support in theater, and vascular surgeon availability. 24, 25 Preparations such as this are likely to be routine when known extreme risk factors such as placenta previa are present, but this risk assessment tool also takes into account when multiple minor risk factors add up and can lead to previously less predictable high blood losses that would not normally trigger the same level of preventative care. A limitation of this study is that it was performed at the single center. However, this provides the additional advantage of having uniform clinical protocols, practice, and documentation for all patients. Another limitation could be the use of EBLs as documented in the notes by trained staff rather than measured blood loss. This is due to the retrospective nature of this study design. Yearly mandatory staff training includes correctly estimating blood loss with pictorial reference cards and has improved estimations of blood loss over recent years. It is noteworthy that, contrary to previous results, 10 the inferred model does not highlight fibroids as major risk factor for blood loss. However, this finding should be interpreted with caution as the current data set had limited number of fibroid cases.
Conclusion
The Leicester Predict PPH tool predicts the risk of significant PPH following CS using preoperative characteristics of the patient. This risk assessment tool showed reliable results when tested for internal validity. The use of this tool in clinical practice will help to plan and execute the strategies to minimize the blood loss in high-risk patients. Such an approach of quantified individualized risk will improve CS surgery safety and will also enable patients to make informed choices.
Further research using a prospective multicenter trial design to validate this toolkit externally is recommended. 
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